Cite
MLA Citation
Makoto Tada et al.. “MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells.” Lung cancer, vol. 133, 2019, pp. 88–95. http://access.bl.uk/ark:/81055/vdc_100085409560.0x000055